The prevalence and importance of frailty in cardiac resynchronization therapy patients

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. BACKGROUND: Frailty, characterized by loss of homeostatic reserves and increased vulnerability to physiological decompensation, res...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuthi, L, Behon, A, Merkel, E, Schwertner, W R, Masszi, R, Veres, B, Kovacs, A, Osztheimer, I, Zima, E, Molnar, L, Geller, L, Kosztin, A, Merkely, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
14.3 - Cardiac Resynchronisation Therapy (CRT)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207441/
http://dx.doi.org/10.1093/europace/euad122.457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207441/
http://dx.doi.org/10.1093/europace/euad122.457

Ejemplares similares